Innovative cell therapy development is driven by iPSC technology, enabling scalable and versatile applications in regenerative medicine. Consistent production supports research and clinical use. Xellera Therapeutics offers integrated solutions that advance iPSC-based therapies in modern cell and gene therapy development.